Protease inhibitors may increase risk of death in people with HIV and heart failure
Ritonavir-boosted protease inhibitors associated with doubled risk of hospital readmission and cardiovascular death Related items fromOnMedica Stroke rate higher in HIV patients £30 million to tackle antimicrobial resistance Single-dose malaria drug eliminates parasite from liver Ibuprofen not a safe alternative to antibiotics for uncomplicated UTIs Too few women take part in many CVD clinical trials
Source: OnMedica Latest News - Category: UK Health Source Type: news
More News: Antimicrobial Resistance | Cardiology | Cardiovascular | Clinical Trials | Heart | Heart Failure | Hospitals | Ibuprofen | Liver | Malaria | Norvir | Parasitic Diseases | Parasitology | Stroke | UK Health | Urology & Nephrology | Women